The European Society of Cardiology guidelines for the management (diagnosis and treatment) of syncope were published in August 2001. Since then, more clinical trials and observational studies have been published, some of which alter the recommendations made in that document. The panel reconvened in September 2003, made revisions where appropriate and developed the consensus recommendations. This executive summary reports the most important changes. Furthermore, since the strategies for the assessment of syncope vary widely among physicians and among hospitals in Europe, we recognised the need to coordinate the evaluation of syncope. The panel sought to define ESC standards for the management of syncope and proposed a model of organisation for the evaluation of the syncope patient. A new section was thus added to the document on this topic.

Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary.

PRIORI, SILVIA GIULIANA;
2004-01-01

Abstract

The European Society of Cardiology guidelines for the management (diagnosis and treatment) of syncope were published in August 2001. Since then, more clinical trials and observational studies have been published, some of which alter the recommendations made in that document. The panel reconvened in September 2003, made revisions where appropriate and developed the consensus recommendations. This executive summary reports the most important changes. Furthermore, since the strategies for the assessment of syncope vary widely among physicians and among hospitals in Europe, we recognised the need to coordinate the evaluation of syncope. The panel sought to define ESC standards for the management of syncope and proposed a model of organisation for the evaluation of the syncope patient. A new section was thus added to the document on this topic.
2004
Cardiovascular & Hematology Research covers all levels of investigation into the normal and pathogenic functions of the heart, vasculature, and soluble blood components. Cell biology of vascular tissue and formed elements of blood, biochemical regulation of thrombosis, therapeutic strategies for treatment of cardiac and vascular diseases are also considered. Resources on hematologic oncology are excluded and are placed in the Oncogenesis & Cancer Research category.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
25
2054
2072
Tematica Ex SIR: Strategie innovative per la diagnosi ed il trattamento di patologie ad elevato rischio cardiovascolare (Classif. Ex SIR:Articoli su riviste ISI )
Ventricular Tachycardia; Syncope; ATP Test
http://www.ncbi.nlm.nih.gov/pubmed/15541843
35
info:eu-repo/semantics/article
262
Brignole, M; Alboni, P; Benditt, Dg; Bergfeldt, L; Blanc, Jj; Thomsen, Pe; Gert van Dijk, J; Fitzpatrick, A; Hohnloser, S; Janousek, J; Kapoor, W; Ken...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/22212
Citazioni
  • ???jsp.display-item.citation.pmc??? 60
  • Scopus 330
  • ???jsp.display-item.citation.isi??? 248
social impact